08/28/2024 3:31 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 12:16 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024 10:35 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024 3:38 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:04 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 9:54 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024 4:35 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/17/2024 4:14 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 3:38 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 3:28 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:30 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 9:28 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 5:04 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 3:10 PM | Crinetics Pharmaceuticals (Subject) Hassard James (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024 12:07 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024 3:32 PM | Crinetics Pharmaceuticals (Issuer) Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 4:31 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 3:32 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:03 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 10:01 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 5:07 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 4:08 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:24 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 3:45 PM | Crinetics Pharmaceuticals (Filer)
| Form S-3ASR | |
06/21/2024 3:31 PM | Crinetics Pharmaceuticals (Subject) Hassard James (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 3:35 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:30 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 10:55 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/28/2024 12:44 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024 7:23 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 5:29 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 3:47 PM | Crinetics Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024 3:48 PM | Crinetics Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024 3:50 PM | Crinetics Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024 4:23 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:36 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 4:09 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:52 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032. Learn more about this much-needed advancement and investment opportunity here. |
04/04/2024 3:17 PM | Crinetics Pharmaceuticals (Subject) Struthers Richard Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:31 PM | Crinetics Pharmaceuticals (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 1:34 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024 4:20 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 5:31 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:32 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:33 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:34 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:35 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:36 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:37 PM | Crinetics Pharmaceuticals (Subject) Fust Matthew K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 3:40 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 5:31 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 3:15 PM | Crinetics Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/11/2024 2:34 PM | Crinetics Pharmaceuticals (Subject) EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
03/06/2024 7:18 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 6:59 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:01 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:01 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 6:57 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 7:05 PM | Crinetics Pharmaceuticals (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
03/01/2024 3:41 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 POS | |
02/28/2024 3:31 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 5:36 PM | Crinetics Pharmaceuticals (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 6:54 AM | Crinetics Pharmaceuticals (Subject) DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 7:50 AM | Crinetics Pharmaceuticals (Subject) FMR LLC (Filed by)
| Form SC 13G | |
01/26/2024 4:50 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 9:28 AM | Crinetics Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/12/2024 3:12 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 11:10 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 7:03 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:43 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:45 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:44 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 4:20 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 10:47 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 5:45 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 4:28 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 3:37 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 3:44 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 12:48 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 3:31 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 10:40 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 3:33 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 3:31 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/06/2023 5:02 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 6:38 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The death of Nvidia? (Ad) Today, I’m warning of another looming catastrophe.
Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out.
You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy...
There's also no escaping that The Big AI Die-Up is coming. So go here now to read my new report The Big AI Die-Up… while you still can. |
11/01/2023 3:44 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023 4:01 PM | Crinetics Pharmaceuticals (Issuer) Krasner Alan Seth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:20 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 3:24 PM | Crinetics Pharmaceuticals (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
09/13/2023 4:19 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
09/13/2023 4:23 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 3:09 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
09/11/2023 5:05 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |